$\require{mediawiki-texvc}$

연합인증

연합인증 가입 기관의 연구자들은 소속기관의 인증정보(ID와 암호)를 이용해 다른 대학, 연구기관, 서비스 공급자의 다양한 온라인 자원과 연구 데이터를 이용할 수 있습니다.

이는 여행자가 자국에서 발행 받은 여권으로 세계 각국을 자유롭게 여행할 수 있는 것과 같습니다.

연합인증으로 이용이 가능한 서비스는 NTIS, DataON, Edison, Kafe, Webinar 등이 있습니다.

한번의 인증절차만으로 연합인증 가입 서비스에 추가 로그인 없이 이용이 가능합니다.

다만, 연합인증을 위해서는 최초 1회만 인증 절차가 필요합니다. (회원이 아닐 경우 회원 가입이 필요합니다.)

연합인증 절차는 다음과 같습니다.

최초이용시에는
ScienceON에 로그인 → 연합인증 서비스 접속 → 로그인 (본인 확인 또는 회원가입) → 서비스 이용

그 이후에는
ScienceON 로그인 → 연합인증 서비스 접속 → 서비스 이용

연합인증을 활용하시면 KISTI가 제공하는 다양한 서비스를 편리하게 이용하실 수 있습니다.

[해외논문] Effect of supplement with lactic-acid producing bacteria on fatigue and physical activity in patients with chronic fatigue syndrome 원문보기

Nutrition journal, v.8 no.1, 2009년, pp.4 - 4  

Sullivan, Åsa (Division of Clinical Microbiology, F82, Department of Laboratory Medicine, Karolinska University Hospital Huddinge, Karolinska Institutet, SE-141 86 Stockholm, Sweden) ,  Nord, Carl E (Division of Clinical Microbiology, F82, Department of Laboratory Medicine, Karolinska University Hospital Huddinge, Karolinska Institutet, SE-141 86 Stockholm, Sweden) ,  Evengård, Birgitta (Division of Clinical Microbiology, F82, Department of Laboratory Medicine, Karolinska University Hospital Huddinge, Karolinska Institutet, SE-141 86 Stockholm, Sweden)

Abstract AI-Helper 아이콘AI-Helper

Disturbances in intestinal microbial ecology and in the immune system of the host have been implicated as a part of the pathogenesis in chronic fatigue syndrome. Probiotic lactic acid producing bacteria have been shown to prevent and alleviate gastrointestinal disturbances and to normalize the cytok...

참고문헌 (33)

  1. Fukuda K Straus SE Hickie I Sharpe MC Dobbins JG Komaroff A The chronic fatigue syndrome: a comprehensive approach to its definition and study. International Chronic Fatigue Syndrome Study Group Ann Intern Med 1994 121 953 9 7978722 

  2. Reeves WC Lloyd A Vernon SD Klimas N Jason LA Bleijenberg G Evengard B White PD Nisenbaum R Unger ER Identification of ambiguities in the 1994 chronic fatigue syndrome research case definition and recommendations for resolution BMC Health Serv Res 2003 3 25 14702202 10.1186/1472-6963-3-25 

  3. Ranjith G Epidemiology of chronic fatigue syndrome Occup Med (Lond) 2005 55 13 9 15699086 10.1093/occmed/kqi012 

  4. Evengard B Jacks A Pedersen NL Sullivan PF The epidemiology of chronic fatigue in the Swedish twin registry Psychological Medicine 2005 35 1 10 10.1017/S0033291704004052 

  5. Evengard B Klimas N Chronic fatigue syndrome: probable pathogenesis and possible treatments Drugs 2002 62 2433 46 12421101 10.2165/00003495-200262170-00003 

  6. Adler RH Chronic fatigue syndrome (cfs) Swiss Med Wkly 2004 134 268 76 15243847 

  7. Patarca R Cytokines and chronic fatigue syndrome Ann N Y Acad Sci 2001 933 185 200 12000020 

  8. Friedberg F Dechene L McKenzie MJ 2nd Fontanetta R Symptom patterns in long-duration chronic fatigue syndrome J Psychosom Res 2000 48 59 68 10750631 10.1016/S0022-3999(99)00077-X 

  9. Whitehead WE Palsson O Jones KR Systematic review of the comorbidity of irritable bowel syndrome with other disorders: what are the causes and implications? Gastroenterology 2002 122 1140 56 11910364 10.1053/gast.2002.32392 

  10. Drossman DA Camilleri M Mayer EA Whitehead WE AGA technical review on irritable bowel syndrome Gastroenterology 2002 123 2108 31 12454866 10.1053/gast.2002.37095 

  11. Madden JA Hunter JO A review of the role of the gut microflora in irritable bowel syndrome and the effects of probiotics Br J Nutr 2002 88 S67 72 12215182 10.1079/BJN2002631 

  12. Butt HL Dunstan RH McGregor NR Roberts TK 'Bacterial colonosis' in patients with persistent fatigue Proceedings of the AHMF International Clinical and Scientific Conference; Sydney, Australia 

  13. Evengård B Gräns H Wahlund E Nord CE Elevated levels of Candida albicans in the faecal microflora of chronic fatigue syndrome patients during the acute phase of illness Scand J Gastroent 2007 

  14. Logan AC Wong C Chronic fatigue syndrome: oxidative stress and dietary modifications Altern Med Rev 2001 6 450 9 11703165 

  15. Sullivan A Nord CE Probiotics and gastrointestinal diseases J Intern Med 2005 257 78 92 15606379 10.1111/j.1365-2796.2004.01410.x 

  16. Halpern GM Prindiville T Blankenburg M Hsia T Gershwin ME Treatment of irritable bowel syndrome with Lacteol Fort: a randomized, double-blind, cross-over trial Am J Gastroenterol 1996 91 1579 85 8759665 

  17. Niedzielin K Kordecki H Birkenfeld B A controlled, double-blind, randomized study on the efficacy of Lactobacillus plantarum 299V in patients with irritable bowel syndrome Eur J Gastroenterol Hepatol 2001 13 1143 7 11711768 10.1097/00042737-200110000-00004 

  18. Nobaek S Johansson ML Molin G Ahrne S Jeppsson B Alteration of intestinal microflora is associated with reduction in abdominal bloating and pain in patients with irritable bowel syndrome Am J Gastroenterol 2000 95 1231 8 10811333 10.1111/j.1572-0241.2000.02015.x 

  19. Sen S Mullan MM Parker TJ Woolner JT Tarry SA Hunter JO Effect of Lactobacillus plantarum 299v on colonic fermentation and symptoms of irritable bowel syndrome Dig Dis Sci 2002 47 2615 20 12452404 10.1023/A:1020597001460 

  20. MA O'Sullivan CA O'Morain Bacterial supplementation in the irritable bowel syndrome. A randomised double-blind placebo-controlled crossover study Dig Liver Dis 2000 32 294 301 11515626 10.1016/S1590-8658(00)80021-3 

  21. Lin MY Yen CL Antioxidative ability of lactic acid bacteria J Agric Food Chem 1999 47 1460 6 10563999 10.1021/jf981149l 

  22. Hessle C Hanson LA Wold AE Lactobacilli from human gastrointestinal mucosa are strong stimulators of IL-12 production Clin Exp Immunol 1999 116 276 82 10337019 10.1046/j.1365-2249.1999.00885.x 

  23. Cross ML Gill HS Can immunoregulatory lactic acid bacteria be used as dietary supplements to limit allergies? Int Arch Allergy Immunol 2001 125 112 9 11435727 10.1159/000053804 

  24. Majamaa H Isolauri E Probiotics: a novel approach in the management of food allergy J Allergy Clin Immunol 1997 99 179 85 9042042 10.1016/S0091-6749(97)70093-9 

  25. Logan AC Venket Rao A Irani D Chronic fatigue syndrome: lactic acid bacteria may be of therapeutic value Med Hypotheses 2003 60 915 23 12699726 10.1016/S0306-9877(03)00096-3 

  26. Collins SL Moore RA McQuay HJ The visual analogue pain intensity scale: what is moderate pain in millimetres? Pain 1997 72 95 7 9272792 10.1016/S0304-3959(97)00005-5 

  27. Ware JE Jr Sherbourne CD The MOS 36-item short-form health survey (SF-36). I. Conceptual framework and item selection Med Care 1992 30 473 83 1593914 10.1097/00005650-199206000-00002 

  28. Fagerberg UL Loof L Merzoug RD Hansson LO Finkel Y Fecal calprotectin levels in healthy children studied with an improved assay J Pediatr Gastroenterol Nutr 2003 37 468 72 14508218 10.1097/00005176-200310000-00013 

  29. Sullivan Å Johansson A Svenungsson B Nord CE Effect of lactobacillus F19 on the emergence of antibiotic-resistant microorganisms in the intestinal microflora J Antimicrob Chemother 2004 54 791 7 15329362 10.1093/jac/dkh406 

  30. Björneholm S Eklöw A Saarela M Mättö J Enumeration and identification of Lactobacillus paracasei subsp. paracasei F19 Microbial Ecology in Health and Disease 2002 7 13 10.1080/089106002760003288 

  31. Reynolds KJ Vernon SD Bouchery E Reeves WC The economic impact of chronic fatigue syndrome Cost Eff Resour Alloc 2004 2 4 15210053 10.1186/1478-7547-2-4 

  32. Cho HJ Hotopf M Wessely S The placebo response in the treatment of chronic fatigue syndrome: a systematic review and meta-analysis Psychosom Med 2005 67 301 13 15784798 10.1097/01.psy.0000156969.76986.e0 

  33. Jason LA Corradi K Torres-Harding S Taylor RR King C Chronic fatigue syndrome: the need for subtypes Neuropsychol Rev 2005 15 29 58 15929497 10.1007/s11065-005-3588-2 

섹션별 컨텐츠 바로가기

AI-Helper ※ AI-Helper는 오픈소스 모델을 사용합니다.

AI-Helper 아이콘
AI-Helper
안녕하세요, AI-Helper입니다. 좌측 "선택된 텍스트"에서 텍스트를 선택하여 요약, 번역, 용어설명을 실행하세요.
※ AI-Helper는 부적절한 답변을 할 수 있습니다.

선택된 텍스트

맨위로